Eugene V Defelice Net Worth

The estimated Net Worth of Eugene V Defelice is at least $1.84 Million dollars as of 12 August 2015. Eugene Defelice owns over 2,000 units of HMS Corp stock worth over $1,838,703 and over the last 14 years Eugene sold HMSY stock worth over $0.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

or

Sign up with Google Sign up with Facebook

Eugene Defelice HMSY stock SEC Form 4 insiders trading

Eugene has made over 2 trades of the HMS Corp stock since 2014, according to the Form 4 filled with the SEC. Most recently Eugene bought 2,000 units of HMSY stock worth $17,580 on 12 August 2015.

The largest trade Eugene's ever made was buying 2,000 units of HMS Corp stock on 12 August 2015 worth over $17,580. On average, Eugene trades about 214 units every 32 days since 2010. As of 12 August 2015 Eugene still owns at least 49,735 units of HMS Corp stock.

You can see the complete history of Eugene Defelice stock trades at the bottom of the page.

What's Eugene Defelice's mailing address?

Eugene's mailing address filed with the SEC is C/O BARNES & NOBLE, INC., 122 FIFTH AVENUE, NEW YORK, NY, 10011.

Insiders trading at HMS Corp

Over the last 22 years, insiders at HMS Corp have traded over $52,929,119 worth of HMS Corp stock and bought 86,410 units worth $1,190,400 . The most active insiders traders include William C Lucia, Daniel Newman Mendelson, and Iii William F Miller. On average, HMS Corp executives and independent directors trade stock every 20 days with the average trade being worth of $938,779. The most recent stock trade was executed by Richard H Stowe on 19 October 2020, trading 3,530 units of HMSY stock currently worth $75,401.

What does HMS Corp do?

HMS advances healthcare by helping organizations reduce costs and improve health outcomes. Through its industry-leading technology, analytics and engagement solutions, HMS saves billions of dollars annually while helping consumers lead healthier lives. HMS provides a broad range of payment accuracy and population health management solutions that help move the healthcare system forward.

Complete history of Eugene Defelice stock trades at HMS Corp

HMS Corp executives and stock owners

HMS Corp executives and other stock owners filed with the SEC include:

• William Lucia,
  Chairman of the Board, President, Chief Executive Officer
• Jeffrey Sherman,
  Chief Financial Officer, Executive Vice President, Treasurer
• Douglas Williams,
  Chief Operating Officer, Executive Vice President
• Emmet OGara,
  Group President, Population Health Management
• Meredith Bjorck,
  Executive Vice President, Corporate Secretary, Chief Legal Officer
• Cora Tellez,
  Lead Independent Director
• Richard Stowe,
  Independent Director
• Ellen Rudnick,
  Independent Director
• Craig Callen,
  Independent Director
• Bart Schwartz,
  Independent Director
• Robert Becker,
  Independent Director
• William Miller,
  Independent Director
• Jeffrey Rideout,
  Independent Director
• Katherine Baicker,
  Independent Director
• Robert Borchert,
  Senior Vice President, Investor Relations
• Jacob Sims,
  Senior Vice President, Chief Technology Officer
• Maria Perrin,
  Executive Vice President, Chief Growth Officer
• David Alexander,
  Chief Human Resource Officer, Senior Vice President, Chief Compliance Officer
• Greg D Aunan,
  SVP, Chief Accounting Officer
• Alex M Ii Azar,
  Director
• Teresa South,
  Chief Administrative Officer
• Robert M Holster,
  President
• Cynthia Nustad,
  CIO
• Emmet O'gara,
  Group Pres., Pop Health Mgmt.
• Semone Wagner,
  EVP, Operations
• Jzaneen Lalani,
  Chief Corporate Counsel
• Edith S Marshall,
  VP and General Counsel
• Walter D Hosp,
  SVP & CFO
• Andrea Benko,
  Executive Vice President
• Joel Portice,
  Division President
• Daniel Newman Mendelson,
  Director
• Ronald D Singh,
  EVP, Managed Care
• Spencer Young,
  President, HealthDataInsights
• Christina Dragonetti,
  
• William S Mosakowski,
  Director
• Joseph M Donabauer,
  
• Eugene V Defelice,
  EVP, General Counsel
• James Timothy Kelly,
  Director
• Michael A Stocker,
  Director
• Sean Curtin,
  
• John David Schmid,
  SVP
• William W Neal,
  Director
• Galen D Powers,
  Director
• Thomas G Archbold,
  Chief Financial Officer
• Philip Rydzewski,
  Chief Financial Officer
• Randolph G Brown,
  Director